Item Type | Name |
Academic Article
|
Genomic high-resolution profiling of single CKpos/CD45neg flow-sorting purified circulating tumor cells from patients with metastatic breast cancer.
|
Academic Article
|
Simultaneous Detection of Disseminated and Circulating Tumor Cells in Primary Breast Cancer Patients.
|
Academic Article
|
Suppression of early hematogenous dissemination of human breast cancer cells to bone marrow by retinoic Acid-induced 2.
|
Academic Article
|
Disseminated tumor cells from the bone marrow of patients with nonmetastatic primary breast cancer are predictive of locoregional relapse.
|
Academic Article
|
EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
|
Academic Article
|
Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer.
|
Academic Article
|
Correction: EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
|
Academic Article
|
Association of CA27.29 and Circulating Tumor Cells Before and at Different Times After Adjuvant Chemotherapy in Patients with Early-stage Breast Cancer - The SUCCESS Trial.
|
Academic Article
|
Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant.
|
Academic Article
|
Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer.
|
Academic Article
|
Circulating Tumor Cells in Early-Stage Breast Cancer.
|
Academic Article
|
A Novel Workflow to Enrich and Isolate Patient-Matched EpCAMhigh and EpCAMlow/negative CTCs Enables the Comparative Characterization of the PIK3CA Status in Metastatic Breast Cancer.
|
Academic Article
|
Evaluation of serum epidermal growth factor receptor (EGFR) in correlation to circulating tumor cells in patients with metastatic breast cancer.
|
Academic Article
|
Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer.
|
Academic Article
|
The clinical relevance of serum vascular endothelial growth factor (VEGF) in correlation to circulating tumor cells and other serum biomarkers in patients with metastatic breast cancer.
|
Academic Article
|
Toward a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multicenter study (CTCTrap).
|
Academic Article
|
Use of Granulocyte-colony Stimulating Factor During Chemotherapy and Its Association With CA27.29 and Circulating Tumor Cells-Results From the SUCCESS A Trial.
|
Academic Article
|
Clinical Relevance of Disseminated Tumor Cells in the Bone Marrow and Circulating Tumor Cells in the Blood of Breast Cancer Patients.
|
Academic Article
|
EpCAMhigh and EpCAMlow circulating tumor cells in metastatic prostate and breast cancer patients.
|
Academic Article
|
Diagnostic leukapheresis for CTC analysis in breast cancer patients: CTC frequency, clinical experiences and recommendations for standardized reporting.
|
Academic Article
|
Label-Free Enrichment and Molecular Characterization of Viable Circulating Tumor Cells from Diagnostic Leukapheresis Products.
|
Academic Article
|
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper.
|
Academic Article
|
The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer.
|
Academic Article
|
Response to Di Cosimo, Torri, and Porcu.
|
Academic Article
|
Diagnostic Leukapheresis Enables Reliable Transcriptomic Profiling of Single Circulating Tumor Cells to Characterize Inter-Cellular Heterogeneity in Terms of Endocrine Resistance.
|
Academic Article
|
Circulating tumor cells in patients with breast cancer dormancy.
|
Academic Article
|
Time is an important factor when processing samples for the detection of disseminated tumor cells in blood/bone marrow by reverse transcription-PCR.
|
Academic Article
|
Detection of disseminated tumor cells in patients with gynecological cancers.
|
Academic Article
|
Influence of platinum-based chemotherapy on disseminated tumor cells in blood and bone marrow of patients with ovarian cancer.
|
Academic Article
|
Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status.
|
Academic Article
|
Systemic spread is an early step in breast cancer.
|
Academic Article
|
Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevance.
|
Academic Article
|
Presence of apoptotic and nonapoptotic disseminated tumor cells reflects the response to neoadjuvant systemic therapy in breast cancer.
|
Academic Article
|
HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial.
|
Academic Article
|
Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer.
|
Academic Article
|
Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials.
|
Academic Article
|
The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer.
|
Academic Article
|
Circulating tumor cells in breast cancer.
|
Academic Article
|
Relationship between circulating tumor cells and peripheral T-cells in patients with primary breast cancer.
|
Academic Article
|
Analysing the mutational status of PIK3CA in circulating tumor cells from metastatic breast cancer patients.
|
Academic Article
|
Presence of disseminated tumor cells in bone marrow correlates with tumor stage and nodal involvement in cervical cancer patients.
|
Academic Article
|
Prognostic relevance of viable circulating tumor cells detected by EPISPOT in metastatic breast cancer patients.
|
Academic Article
|
Prevalence and prognostic value of disseminated tumor cells in primary endometrial, cervical and vulvar cancer patients.
|
Academic Article
|
Primary systemic therapy does not eradicate disseminated tumor cells in breast cancer patients.
|
Academic Article
|
Disseminated tumor cells as a monitoring tool for adjuvant therapy in patients with primary breast cancer.
|
Academic Article
|
Prognostic relevance of induced and spontaneous apoptosis of disseminated tumor cells in primary breast cancer patients.
|
Academic Article
|
Expression of stem cell and epithelial-mesenchymal transition markers in circulating tumor cells of breast cancer patients.
|
Academic Article
|
Prognostic relevance of disseminated tumour cells from the bone marrow of early stage breast cancer patients - results from a large single-centre analysis.
|
Academic Article
|
Molecular profiling of single circulating tumor cells with diagnostic intention.
|
Academic Article
|
Prognostic Relevance of Circulating Tumor Cells in Molecular Subtypes of Breast Cancer.
|
Academic Article
|
Detection and prevalence of disseminated tumor cells from the bone marrow of early stage male breast cancer patients.
|
Academic Article
|
Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program.
|
Academic Article
|
Circulating tumor cells in breast cancer--current status and perspectives.
|
Academic Article
|
Liquid Biopsy in Metastasized Breast Cancer as Basis for Treatment Decisions.
|
Academic Article
|
Isolation and characterization of circulating tumor cells using a novel workflow combining the CellSearch? system and the CellCelector?.
|
Academic Article
|
Relationship Between Hematogenous Tumor Cell Dissemination and Cellular Immunity in DCIS Patients.
|
Academic Article
|
Gene expression profiling of single circulating tumor cells in?ovarian cancer - Establishment of a multi-marker gene panel.
|
Academic Article
|
Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients.
|
Academic Article
|
Frequent detection of PIK3CA mutations in single circulating tumor cells of patients suffering from HER2-negative metastatic breast cancer.
|
Academic Article
|
Potential Role of Circulating Tumor Cell Detection and Monitoring in Breast Cancer: A Review of Current Evidence.
|
Academic Article
|
Analysis of DNA methylation in single circulating tumor cells.
|
Academic Article
|
Clinical Relevance of Serum HER2 and Circulating Tumor Cell Detection in Metastatic Breast Cancer Patients.
|
Academic Article
|
Enrichment, Isolation and Molecular Characterization of EpCAM-Negative Circulating Tumor Cells.
|
Academic Article
|
The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial.
|
Academic Article
|
Prognostic Impact of Circulating Tumor Cells for Breast Cancer Patients Treated in the Neoadjuvant "Geparquattro" Trial.
|
Academic Article
|
Quantifying HER-2 expression on circulating tumor cells by ACCEPT.
|
Academic Article
|
Navigation through inter- and intratumoral heterogeneity of endocrine resistance mechanisms in breast cancer: A potential role for Liquid Biopsies?
|
Academic Article
|
Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.
|
Academic Article
|
Filtration based assessment of CTCs and CellSearch? based assessment are both powerful predictors of prognosis for metastatic breast cancer patients.
|
Academic Article
|
Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study.
|
Academic Article
|
Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial.
|
Academic Article
|
Prevalence of circulating tumor cells in early breast cancer patients 2 and 5?years after adjuvant treatment.
|
Academic Article
|
Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis.
|
Academic Article
|
Detection of circulating tumor cells in colorectal cancer patients using the GILUPI CellCollector: results from a prospective, single-center study.
|
Academic Article
|
Detection of ESR1 Mutations in Single Circulating Tumor Cells on Estrogen Deprivation Therapy but Not in Primary Tumors from Metastatic Luminal Breast Cancer Patients.
|
Academic Article
|
Determination of the androgen receptor status of circulating tumour cells in metastatic breast cancer patients.
|
Academic Article
|
Clinical relevance of circulating tumor cells in ovarian, fallopian tube and peritoneal cancer.
|
Academic Article
|
53BP1 Accumulation in Circulating Tumor Cells Identifies Chemotherapy-Responsive Metastatic Breast Cancer Patients.
|
Academic Article
|
Serial Analysis of Circulating Tumor Cells in Metastatic Breast Cancer Receiving First-Line Chemotherapy.
|
Academic Article
|
Liquid Biopsy in Metastatic Breast Cancer: Current Role of Circulating Tumor Cells and Circulating Tumor DNA.
|
Academic Article
|
Disseminated tumor cells in bone marrow may affect prognosis of patients with gynecologic malignancies.
|
Academic Article
|
Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients.
|
Academic Article
|
Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells.
|
Academic Article
|
Information from CTC measurements for metastatic breast cancer prognosis-we should do more than selecting an "optimal cut point".
|
Academic Article
|
Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial.
|
Academic Article
|
External quality assurance of circulating tumor cell enumeration using the CellSearch(?) system: a feasibility study.
|
Academic Article
|
Persistence of disseminated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse--a European pooled analysis.
|
Academic Article
|
[Mechanisms of tumour cell dissemination and methods for detection of circulating tumour cells in transitional cell carcinoma].
|
Academic Article
|
Changing levels of circulating tumor cells in monitoring chemotherapy response in patients with metastatic breast cancer.
|
Academic Article
|
The influence of removal of primary tumor on incidence and phenotype of circulating tumor cells in primary breast cancer.
|
Academic Article
|
Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients.
|
Academic Article
|
Impaired bone microenvironment: correlation between bone density and presence of disseminated tumor cells.
|
Academic Article
|
Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells.
|
Academic Article
|
Clinical implications of the detection of circulating tumor cells in breast cancer patients.
|
Academic Article
|
Influence of zoledronic acid on disseminated tumor cells in primary breast cancer patients.
|
Academic Article
|
HER2-positive DTCs/CTCs in breast cancer.
|
Academic Article
|
Isolated, disseminated and circulating tumour cells in prostate cancer.
|
Academic Article
|
Prognostic impact of circulating tumor cells assessed with the CellSearch System? and AdnaTest Breast? in metastatic breast cancer patients: the DETECT study.
|
Academic Article
|
[Detection of disseminated tumor cells in the bone marrow of breast cancer patients with a new molecular method].
|
Academic Article
|
Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patients.
|
Academic Article
|
The presence and prognostic impact of apoptotic and nonapoptotic disseminated tumor cells in the bone marrow of primary breast cancer patients after neoadjuvant chemotherapy.
|
Academic Article
|
Detection and clinical relevance of hematogenous tumor cell dissemination in patients with ductal carcinoma in situ.
|
Academic Article
|
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data.
|
Academic Article
|
Circulating and disseminated tumor cells in ovarian cancer: a systematic review.
|
Academic Article
|
International study on inter-reader variability for circulating tumor cells in breast cancer.
|
Academic Article
|
Monitoring in metastatic breast cancer: is imaging outdated in the era of circulating tumor cells?
|
Academic Article
|
Circulating tumor cells predict survival in early average-to-high risk breast cancer patients.
|
Academic Article
|
Tumor cell dissemination to the bone marrow and blood is associated with poor outcome in patients with metastatic breast cancer.
|
Concept
|
Neoplastic Cells, Circulating
|
Academic Article
|
Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program.
|
Academic Article
|
Multiparametric Circulating Tumor Cell Analysis to Select Targeted Therapies for Breast Cancer Patients.
|
Academic Article
|
Discordance in Human Epidermal Growth Factor Receptor 2 (HER2) Phenotype Between Primary Tumor and Circulating Tumor Cells in Women With HER2-Negative Metastatic Breast Cancer.
|
Academic Article
|
Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation.
|
Academic Article
|
Implementing microwell slides for detection and isolation of single circulating tumor cells from complex cell suspensions.
|
Academic Article
|
Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of First Metastasis-Results from the Adjuvant SUCCESS A Trial.
|
Academic Article
|
Comparative analysis of EpCAM high-expressing and low-expressing circulating tumour cells with regard to their clonal relationship and clinical value.
|
Academic Article
|
The effect of denosumab on disseminated tumor cells (DTCs) of breast cancer patients with neoadjuvant treatment: a GeparX translational substudy.
|
Academic Article
|
Association Between Obesity and Circulating Tumor Cells in Early Breast Cancer Patients.
|